Literature DB >> 24535130

Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies.

T Konuma1, S Kato1, J Ooi2, M Oiwa-Monna1, Y Ebihara1, S Mochizuki1, K Yuji1, N Ohno1, T Kawamata1, N Jo1, K Yokoyama1, K Uchimaru1, A Tojo1, S Takahashi1.   

Abstract

Donor-recipient sex incompatibility has been associated with transplant outcomes in allogeneic hematopoietic SCT. Such outcomes might be because mHA encoded by Y chromosome genes could be immunological targets for allogeneic T cells and B cells to induce GVHD, GVL effect and graft failure. However, its effect on the outcome of cord blood transplantation (CBT) is yet to be clarified. We retrospectively analyzed 191 adult patients who received single-unit CBT after myeloablative conditioning for malignant disease in our institute. In multivariate analysis, male recipients with female donors had a higher incidence of extensive chronic GVHD (hazard ratio (HR) 2.97, P=0.02), and female recipients with male donors had a lower incidence of platelet engraftment (HR 0.56, P=0.02) compared with female recipients with female donors as the reference. Nevertheless, there was no increase in mortality following sex-incompatible CBT. These data suggested that donor-recipient sex compatibility does not have a significant impact on survival after myeloablative CBT for hematological malignancies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24535130     DOI: 10.1038/bmt.2014.10

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  37 in total

Review 1.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Authors:  T A Gooley; W Leisenring; J Crowley; B E Storer
Journal:  Stat Med       Date:  1999-03-30       Impact factor: 2.373

2.  Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

Authors:  David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2004-12-21       Impact factor: 22.113

3.  Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies.

Authors:  Juliet N Barker; Andromachi Scaradavou; Cladd E Stevens
Journal:  Blood       Date:  2009-12-22       Impact factor: 22.113

4.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

5.  Characteristics of chronic GVHD after cord blood transplantation.

Authors:  L F Newell; M E D Flowers; T A Gooley; F Milano; P A Carpenter; P J Martin; C Delaney
Journal:  Bone Marrow Transplant       Date:  2013-04-15       Impact factor: 5.483

6.  Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation.

Authors:  Naofumi Matsuno; Atsushi Wake; Naoyuki Uchida; Kazuya Ishiwata; Hideki Araoka; Shinsuke Takagi; Masanori Tsuji; Hisashi Yamamoto; Daisuke Kato; Yoshiko Matsuhashi; Sachiko Seo; Kazuhiro Masuoka; Shigesaburo Miyakoshi; Shigeyoshi Makino; Akiko Yoneyama; Yoshinobu Kanda; Shuichi Taniguchi
Journal:  Blood       Date:  2009-06-17       Impact factor: 22.113

7.  Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

Authors:  Eliane Gluckman; Vanderson Rocha; William Arcese; Gérard Michel; Guillermo Sanz; Ka-Wah Chan; Tsuneo A Takahashi; Juan Ortega; Alexandra Filipovich; Franco Locatelli; Shigetaka Asano; Franca Fagioli; Marcus Vowels; Anne Sirvent; Jean-Philippe Laporte; Karin Tiedemann; Sergio Amadori; Manuel Abecassis; Pierre Bordigoni; Blanca Diez; Peter J Shaw; Ajay Vora; Maurizio Caniglia; Federico Garnier; Irina Ionescu; Joan Garcia; Gesine Koegler; Paolo Rebulla; Sylvie Chevret
Journal:  Exp Hematol       Date:  2004-04       Impact factor: 3.084

8.  Unrelated cord blood transplants in adults with hematologic malignancies.

Authors:  William Arcese; Vanderson Rocha; Myriam Labopin; Guillermo Sanz; Anna Paola Iori; Marcos de Lima; Anne Sirvent; Alessandro Busca; Shigheta Asano; Irina Ionescu; Peter Wernet; Eliane Gluckman
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

Review 9.  Risk assessment in haematopoietic stem cell transplantation: impact of donor-recipient sex combination in allogeneic transplantation.

Authors:  Gösta Gahrton
Journal:  Best Pract Res Clin Haematol       Date:  2007-06       Impact factor: 3.020

10.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

View more
  3 in total

1.  Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Chien-Ting Chen; Chun-Yu Liu; Yuan-Bin Yu; Chia-Jen Liu; Liang-Tsai Hsiao; Jyh-Pyng Gau; Tzeon-Jye Chiou; Jing-Hwang Liu; Yao-Chung Liu
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

2.  Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.

Authors:  Kavita Raj; Dirk-Jan Eikema; Vipul Sheth; Linda Koster; Liesbeth C de Wreede; Didier Blaise; Carmela Di Grazia; Yener Koc; Victoria Potter; Patrice Chevallier; Lucia Lopez-Corral; Depei Wu; Stephan Mielke; Johan Maertens; Ellen Meijer; Anne Huynh; Jakob Passweg; Thomas Luft; Jose Antonio Pérez-Simón; Fabio Ciceri; Agnieszka Piekarska; G Hayri Ozsan; Nicolaus Kröger; Marie Robin; Ibrahim Yakoub-Agha
Journal:  Blood Cancer J       Date:  2022-09-28       Impact factor: 9.812

3.  Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Frédéric Baron; Myriam Labopin; Annalisa Ruggeri; Mohamad Mohty; Guillermo Sanz; Noel Milpied; Andrea Bacigalupo; Alessandro Rambaldi; Francesca Bonifazi; Alberto Bosi; Jorge Sierra; Ibrahim Yakoub-Agha; Josep Maria Ribera Santasusana; Eliane Gluckman; Arnon Nagler
Journal:  J Hematol Oncol       Date:  2015-10-06       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.